T cells was positively correlated with age and was not associated with plasma viral load or CD4 T cell levels. In children receiving HAART, the frequency of HIV-specific IFNg-producing CD8 T cells was directly correlated with plasma viral load, and its association with age remained significant. In conclusion, the frequency of HIV-specific IFN-g-producing CD8 T cells in children is primarily determined by both age and plasma viral load.
of the immune system combined with the reduction of antigenic stimulation impairs the generation of HIV-specific T cells during the first months of life in treated HIV-infected children [4] [5] [6] [7] . However, the relationships between the frequency of HIV-specific CD8 T cells and age, treatment, viral replication, and immunodeficiency are less well established in older children [4, [7] [8] [9] [10] [11] .
The aims of the present study were, first, to determine the associations between HIV-specific CD8 T cells, age, plasma viral load, and major biological parameters of HIV infection and, second, to determine the impact that antiretroviral treatments have on these associations. Ex vivo IFN-g-producing CD8 T cells specific for HIV Env, Gag, and Pol antigens were measured using an enzyme-linked immunospot (ELISPOT) assay described elsewhere [12] . Correlations between the frequency of HIV-specific IFN-g-producing CD8 T cells, age, and major biological parameters of HIV infection were determined for 55 HIV-1-infected children who were not receiving highly active antiretroviral therapy (HAART) and 70 HIV-1-infected children who were receiving HAART.
Patients, materials, and methods. All children were prospectively followed at Hô pital Necker, Paris. The local ethics committee approved the study. Legal guardians gave informed consent before inclusion of the children in the study. Two crosssectional studies were performed in accordance with the treatment status at the time of the assay.
Fifty-five children not receiving combination therapy including nonnucleoside reverse-transcriptase inhibitors (NNRTIs) or protease inhibitors (PIs) for at least 6 months were selected for the first study (table 1) . At the time of the assay, 2 children !1 month old were receiving zidovudine, 5 children had been receiving 2 nucleoside reverse-transcriptase inhibitors (NRTIs) for a of months, and 48 were not receiving mean ‫ע‬ SD 63 ‫ע‬ 7 antiretroviral drugs. Nineteen of the 55 children had previously received HAART including NNRTIs or PIs. For these previously treated children, data from the ELISPOT assay performed closest to the 12-month point of treatment interruption were selected for analysis. The 19 children who had previously received NNRTIs or PIs and the remaining 36 children were not significantly different in terms of age, plasma viral load, and CD4 T cell percentage ( , analysis of variance [ANOVA]), and P 1 .05 the data for both subgroups were analyzed together.
The second study included children receiving at least 3 drugs, including at least 1 NNRTI or 1 PI (table 2) . Only children treated for 16 months were included. For each child, data from the time point closest to the median duration of treatment in the studied group (18 months) were selected for analysis. Of the 70 children, 44 were receiving their first combination therapy, and the remaining 26 had received several combination therapy regimens before the present one. Correlations were similar for both subgroups, and data from both subgroups were analyzed together.
A standard IFN-g-based ELISPOT assay was performed as described elsewhere [12] . Results presented were obtained using peripheral blood mononuclear cells (PBMCs) per well, . The Amplicor HIV-1 Monitor test (Roche) was used to quantitate HIV-1 RNA in plasma. The cutoff value was 2.6 log 10 HIV RNA copies/mL for the classic assay and 1.7 log 10 HIV RNA copies/mL for the ultrasensitive assay. CD4 and CD8 T cell percentages and absolute cell counts were measured in fresh wholeblood samples by use of 4-color flow-cytometric analysis (XL Flow Cytometer; Beckman-Coulter), and cells positive for CD45, CD3, CD4, or CD8 were measured with fluorescent beads (Flowcount beads; Beckman-Coulter) as an internal standard.
Differences between groups were evaluated using the x 2 test for qualitative variables and ANOVA for continuous variables. Associations between quantitative variables were defined by Pearson's correlations or partial correlations. Partial correlations measure the strength of the relationship between 2 variables, controlling for the effect of у1 other variable. All P values were 2 tailed, and was considered to be statis-P р .05 tically significant. The analysis was performed with Stata software (version 8; StataCorp).
Results. We measured the frequency of HIV-specific IFNg-producing CD8 T cells in the peripheral blood of 55 children not receiving HAART (see table 1 for patients' characteristics). The frequency of HIV-specific IFN-g-producing cells was positively correlated with age and CD8 T cell percentage and was negatively correlated with CD4 T cell count; also, weak but significant negative correlations with plasma viral load and CD4 T cell percentage were observed (figure 1). In children, age is strongly correlated with most major biological parameters of HIV infection. In the study population, age was significantly correlated with plasma viral load ( ; ), CD8 r p Ϫ0.475 P ! .0002 T cell percentage ( ; ), CD4 T cell count r p 0.518 P ! .0001 ( ; ), and CD8 T cell count ( ; r p Ϫ0.537 P ! .00001 r p Ϫ0.468 ). Furthermore, virological and immunological pa-P ! .0003 rameters were correlated with each other (data not shown). Therefore, associations between HIV-specific IFN-g-producing CD8 T cell frequencies and various parameters were determined using partial correlations, controlling for the effect of all other variables. When all parameters were taken into account to calculate correlations, age was the only one that was significantly correlated with the frequency of HIV-specific IFN-g-producing CD8 T cells (table 3 ). In conclusion, in the absence of HAART, the frequency of HIV-specific IFN-g-producing CD8 T cells among PBMCs in children is associated with age and is independent of major biological parameters of HIV infection.
In the analysis presented above, the frequency of HIV-specific IFN-g-producing CD8 T cells as determined by the ELISPOT assay was expressed per PBMCs, as is usual. It is unclear 6 1 ϫ 10 whether this mode of expression is the most relevant to study associations with major biological parameters of HIV infection. Indeed, young children have a low frequency of HIV-specific IFN-g-producing CD8 T cells among PBMCs but have a high number of PBMCs per cubic millimeter of blood. So, the number of HIV-specific IFN-g-producing CD8 T cells per cubic millimeter of blood might be independent of age, even if the CD8 T cell frequency among PBMCs increases with age. In addition, CD4 and CD8 T cell percentages and cell counts vary with age in uninfected children. Therefore, results from the ELISPOT assay were expressed as the number of responding cells among CD8 T cells or per cubic millimeter of blood, and correlations with age and viral and immunological parameters were calculated (table 3). The frequency of HIV-specific IFNg-producing CD8 T cells expressed as the number of responding cells among PBMCs, among CD8 T cells, 6 6 1 ϫ 10 1 ϫ 10 or per cubic millimeter of blood did not significantly change the correlations with the tested parameters. The only exception was that a significant association was found between the number of HIV-specific IFN-g-producing CD8 T cells per cubic millimeter of blood and CD8 T cell count. Altogether, the results showed that the frequency of HIV-specific IFN-g-producing CD8 T cells can be expressed in several ways without affecting its association with most other major biological parameters of HIV infection.
Next, correlations between the frequency of HIV-specific IFN-g-producing CD8 T cells, age, and major biological parameters of HIV infection were evaluated in 70 children receiving HAART including at least 1 NNRTI or 1 PI (table 2) . The strongest correlation was observed with plasma viral load: children with suppressed viremia had a lower frequency of HIVspecific IFN-g-producing CD8 T cells, and this supports the hypothesis that the size of the pool of these cells is determined by continuous antigenic stimulation. The correlations between the frequency of HIV-specific IFN-g-producing CD8 T cells and T cell subsets were similar in children receiving and not receiving HAART (table 3) . The frequency of HIV-specific IFNg-producing CD8 T cells was positively correlated with age, but the correlation was weaker than that in children not receiving HAART. Indeed, a significant proportion of children у5 years old receiving HAART have low or undetectable HIVspecific IFN-g-producing CD8 T cell responses (compare figure 1A and G). Partial correlations confirmed that the frequency of HIV-specific IFN-g-producing CD8 T cells was positively correlated with both age and plasma viral load but was not correlated with CD4 and CD8 T cell levels.
Discussion. In the present study, we report the associations between the frequency of HIV-specific IFN-g-producing CD8 T cells, age, and major biological parameters of HIV infection. We showed that, in children not receiving HAART, the frequency of HIV-specific IFN-g-producing CD8 T cells is dependent on age but is unrelated to plasma viral load or CD4 and CD8 T cell levels, whereas, in children receiving HAART, plasma viral load is a critical determinant of the frequency of HIV-specific IFN-g-producing CD8 T cells.
A major conclusion of the present study is that, in the absence of HAART, age is the major factor that is correlated with the HIV-specific IFN-g-producing CD8 T cell response in children. One explanation for this association is the link between age and the rate of disease progression: the oldest children have survived for several years after infection without receiving HAART and are therefore more likely to be slow progressors than are the youngest children. Another explanation is the immaturity of the children's immune system: decreased IFN-g production by HIV-specific CD8 T cells in young children is in accordance with the general impairment of IFN-g production in infants and the impairment of their antigen-presenting cells [1, 2] . Furthermore, HIV suppresses numerous immune functionsin particular, those of antigen-presenting cells that are required to induce CD4 and CD8 T cell responses, such as interleukin-12 production. Previous studies have proposed that low HIV-specific IFNg-producing CD8 T cell responses persist until children are 6 months [4] or 4 years [11] old. Our opinion is that neither these studies nor the present one have sufficient power to define a threshold for age-related immune competence. Furthermore, various rates of HIV-induced CD4 T cell depletion will affect the kinetics of immune responses in children. However, we want to underscore that the results of the present study and those from other research groups have demonstrated the decreased ability of newborns to generate HIV-specific IFN-gproducing CD8 T cells during acute infection [4] [5] [6] [7] 11] . Because the magnitude or breadth of CD8 T cell responses is inversely correlated with plasma viral load during primary infection in adults, the decreased CD8 T cell response may explain the persistence of high levels of HIV replication that occurs for several years in perinatally infected children [3] .
Another major conclusion of the present study is that, in children receiving HAART, suppression of viral replication is associated with a decreased frequency of HIV-specific IFN-gproducing CD8 T cells, which is in accordance with the findings of some, but not all, studies [7] [8] [9] [10] [11] . In the present study, a significant number of children receiving HAART had detectable HIV replication that might be explained by poor adherence and/or drug-resistant virus. Unfortunately, these 2 issues were not fully documented in the present study, and we could not address the fate of HIV-specific IFN-g-producing CD8 T cell responses in children with discordant responses to treatment (i.e., poor virologic response associated with good immunologic response).
In conclusion, we observed low frequencies of HIV-specific IFN-g-producing CD8 T cells in young children that might be explained by both the general immaturity of the immune system in newborns and HIV-induced immune suppression. In children receiving HAART, the level of viral replication was the major determinant of the intensity of the HIV-specific IFN-gproducing CD8 T cell response. These data support the hypothesis that therapeutic vaccination to expand the HIV-specific IFN-g-producing CD8 T cell pool might be useful for young children with low plasma viral loads, who have the lowest antiviral response.
